| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.3M | -46.5% |
| Cost of Revenue | $3.3M | -66.3% |
| R&D Expense | $1.4M | -8.1% |
| SG&A Expense | $14.5M | -19.6% |
| Operating Income | -$13.9M | +25.9% |
| Pre-tax Income | -$13.2M | +15.6% |
| Income Tax | $8K | -42.9% |
| Net Income | -$14.0M | +9.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.5M | -68.4% |
| Short-term Investments | $5.1M | — |
| Accounts Receivable | $514K | -60.1% |
| Inventory | $2.0M | -23.8% |
| Current Assets | $15.0M | -41.1% |
| Total Assets | $19.7M | -31.9% |
| Current Liabilities | $3.6M | -14.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.3M | -9.4% |
| Capital Expenditures | $5K | -93.1% |
| Investing Cash Flow | -$4.3M | -406.6% |
| Financing Cash Flow | $5.5M | +22.0% |
| Free Cash Flow | -$15.3M | -8.9% |
| Total Liabilities |
| $7.0M |
| -12.7% |
| Stockholders' Equity | $12.8M | -38.9% |